MissionIR Articles
-
International Stem Cell Corporation (ISCO) Uses Multiple Business Units to Generate Even More Revenue
International Stem Cell Corporation (OTC: ISCO) focuses on utilizing patented human parthenogenetic stem cells (hPSC), developed from unfertilized embryos, to treat Parkinson’s, retinal, and liver diseases where replacing dead and dying cells with new ones…
Search Articles
Latest Articles
- Wearable Devices Ltd. (NASDAQ: WLDS): How Neural Interface Patents Are Securing the Future of Touchless Control
- MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) CEO to Present at H.C. Wainwright Global Investment Conference
- MissionIRNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Reports Strong Q2/25 Results, Targets Profitability in Early 2026
- Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Advances Sustainable Development in Alaska’s Ambler Mining District
- SuperCom Ltd. (NASDAQ: SPCB) Secures New U.S. Contracts, Expands Presence into 11th State in Under a Year